Prasol Chemicals IPO: An Overview
Prasol Chemicals Ltd., a leading specialty chemicals producer based in Navi Mumbai, has applied for an initial public offering (IPO) to raise up to Rs 500 crore in the stock market. The company has filed a draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) to sell shares worth up to Rs 500 crore.
IPO Details
The IPO consists of a fresh issue of equity shares of face value of Rs 2 each, aggregating up to Rs 80 crore, and an offer for sale (OFS) by promoters worth up to Rs 420 crore. The company plans to utilise up to Rs 60 crore from the net proceeds in the fresh issue towards repayment of debt. As of August 31, 2025, the total sanctioned and outstanding indebtedness (excluding accrued interest) was Rs 454 crore and Rs 296 crore, respectively.
The remaining funds will be deployed for general corporate purposes. Ten promoter entities will offload equity via the OFS. DAM Capital Advisors Ltd. is the sole merchant banker to the IPO.
Company Overview
Prasol Chemicals manufactures acetone and phosphorous-based specialty chemicals and other specialty chemicals involving complex and differentiated chemistries. The company has over 150 specialty chemical products and 1,107 customers and exports to 69 countries, as of July 31, 2025, as per the DRHP.
Exports contributed nearly 30% of the revenue in the financial year 2025. Prasol Chemicals operates manufacturing facilities in Maharashtra’s Khopoli and Mahad, with an aggregate installed capacity of 87,914 metric tonnes per annum.
Notable Clients and Financial Performance
Notable clients of Prasol Chemicals include Alembic Pharmaceuticals Ltd., Bharat Rasayan Ltd., Coromandel International Ltd., Rossari Biotech Ltd., and Supriya Lifescience Ltd..
The company generated a revenue of Rs 1,012 crore in FY25, compared to Rs 876 crore in FY24 and Rs 930 crore the previous year. Operating margin improved to 8.67% in the last fiscal, from 6.91% in FY24. Net profit came in at Rs 43.6 crore in FY25, more than double from Rs 18 crore a year ago.
Investment Rationale
Investors looking to diversify their portfolio and tap into the growing demand for specialty chemicals may consider investing in the Prasol Chemicals IPO. The company’s strong product portfolio, notable client base, and improving financial performance make it an attractive investment opportunity.
However, investors must also consider the risks associated with the IPO, including the company’s high debt levels and the competitive nature of the specialty chemicals industry. It is essential to carefully evaluate the company’s financials, management team, and industry trends before making an investment decision.
For more information on the Prasol Chemicals IPO, including the IPO valuation, IPO subscription status, and IPO allotment status, please visit our website.
Conclusion
In conclusion, the Prasol Chemicals IPO offers investors an opportunity to invest in a leading specialty chemicals producer with a strong product portfolio and improving financial performance. However, investors must carefully evaluate the company’s financials, management team, and industry trends before making an investment decision.